Dandavino R - Search Results

1

Sirolimus Immunoprophylaxis and Renal Histological Changes in Long-Term Cardiac Transplant Recipients: A Pilot Study.

White M, Boucher A, Dandavino R, Fortier A, Pelletier GB, Racine N, Ducharme A, de Denus S, Carrier M, Collette S. White M, et al. Among authors: dandavino r. Ann Pharmacother. 2014 Jul;48(7):837-846. doi: 10.1177/1060028014527723. Epub 2014 Apr 16. Ann Pharmacother. 2014. PMID: 24740466

2

Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.

Tran D, Vallée M, Collette S, Senécal L, Lafrance JP, Dandavino R, Boucher A. Tran D, et al. Among authors: dandavino r. Exp Clin Transplant. 2014 Aug;12(4):323-7. doi: 10.6002/ect.2013.0165. Epub 2014 May 19. Exp Clin Transplant. 2014. PMID: 24844288 Free article. Review.

3

The incidence, management, and evolution of rapamycin-related side effects in kidney transplant recipients.

Verhave J, Boucher A, Dandavino R, Collette S, Senécal L, Hebert MJ, Girardin C, Cardinal H. Verhave J, et al. Among authors: dandavino r. Clin Transplant. 2014 May;28(5):616-22. doi: 10.1111/ctr.12361. Epub 2014 Apr 19. Clin Transplant. 2014. PMID: 24654608

4

Treatment of Polyomavirus-Associated Nephropathy With the Association of Sirolimus and Leflunomide.

Lamarche C, Boucher A, Dandavino R, Senécal L, Collette S, Tran D, Vallée M. Lamarche C, et al. Among authors: dandavino r. Exp Clin Transplant. 2015 Dec;13(6):607-8. Exp Clin Transplant. 2015. PMID: 26643679 Free article. No abstract available.

5

Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.

Boucher A, Lord H, Collette S, Morin M, Dandavino R. Boucher A, et al. Among authors: dandavino r. Transplant Proc. 2006 Dec;38(10):3506-8. doi: 10.1016/j.transproceed.2006.10.127. Transplant Proc. 2006. PMID: 17175316

6

Risk-benefit of OKT3 prophylaxis in immunologic high-risk cadaver kidney transplant recipients.

Cogny-Van Weydevelt F, Prud'Homme L, Boucher A, Dandavino R. Cogny-Van Weydevelt F, et al. Among authors: dandavino r. Transplant Proc. 1997 Nov;29(7A):32S-34S. doi: 10.1016/s0041-1345(97)80009-7. Transplant Proc. 1997. PMID: 9366926 No abstract available.

7

Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients.

Boucher A, Masse M, Lauzon L, Morin M, Dandavino R. Boucher A, et al. Among authors: dandavino r. Transplant Proc. 2002 Aug;34(5):1799-802. doi: 10.1016/s0041-1345(02)03083-x. Transplant Proc. 2002. PMID: 12176582 No abstract available.

8

Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study.

Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A. Cardinal H, et al. Among authors: dandavino r. Transplant Proc. 2009 Oct;41(8):3308-10. doi: 10.1016/j.transproceed.2009.08.049. Transplant Proc. 2009. PMID: 19857737

9

A pharmacoeconomic intrapatient comparison of Sandimmune capsules and Sandimmune oral solution in kidney transplant recipients.

Dandavino R, Boucher A, Gagne M, Labelle B. Dandavino R, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):985-6. Transplant Proc. 1991. PMID: 1989353 No abstract available.

10

Initial bone loss in kidney transplant recipients: a prospective study.

Masse M, Girardin C, Ouimet D, Dandavino R, Boucher A, Madore F, Hébert MJ, Leblanc M, Pichette V. Masse M, et al. Among authors: dandavino r. Transplant Proc. 2001 Feb-Mar;33(1-2):1211. doi: 10.1016/s0041-1345(00)02390-3. Transplant Proc. 2001. PMID: 11267262 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters